Weber Shares Insight on Future of Immunotherapy in Melanoma – OncLive
OncLive |
Weber Shares Insight on Future of Immunotherapy in Melanoma
OncLive Weber: As we all know, immunotherapy for melanoma has revolutionized how we treat the disease. It started out with the best news, which was the long-term survival data that we had from the original randomized trial of ipilimumab plus nivolumab versus … |
